Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek Mittal

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
JCI Insight|July 13, 2018
Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survivalGeoffrey J Markowitz, Lauren S Havel, Michael Jp Crowley, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progressionJunbum Kim, Hiranmayi Ravichandran, Liron Yoffe, et al.
Cell Reports|January 23, 2020
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast CancerShira Yomtoubian, Sharrell B Lee, Akanksha Verma, et al.
Nature|July 23, 2004
Role of transposable elements in heterochromatin and epigenetic controlZachary Lippman, Anne-Valérie Gendrel, Michael Black, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2025
Longitudinal Genomic Analysis of Five Cases of Recurrent ThymomasYongfeng He, Peter Waltman, Troy Kane, et al.
Cancer Research|January 28, 2012
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transitionDingcheng Gao, Natasha Joshi, Hyejin Choi, et al.
Oncotarget|November 19, 2016
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancerMichael John Sax, Christin Gasch, Vineel Rag Athota, et al.
Nature Communications|December 16, 2021
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasisDivya Ramchandani, Mirela Berisa, Diamile A Tavarez, et al.
Nature|November 13, 2015
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistanceKari R Fischer, Anna Durrans, Sharrell Lee, et al.
Science Translational Medicine|September 1, 2017
Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosisZhongwei Cao, Tinghong Ye, Yue Sun, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
JCI Insight|July 13, 2018
Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survivalGeoffrey J Markowitz, Lauren S Havel, Michael Jp Crowley, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progressionJunbum Kim, Hiranmayi Ravichandran, Liron Yoffe, et al.
Cell Reports|January 23, 2020
Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast CancerShira Yomtoubian, Sharrell B Lee, Akanksha Verma, et al.
Nature|July 23, 2004
Role of transposable elements in heterochromatin and epigenetic controlZachary Lippman, Anne-Valérie Gendrel, Michael Black, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 22, 2025
Longitudinal Genomic Analysis of Five Cases of Recurrent ThymomasYongfeng He, Peter Waltman, Troy Kane, et al.
Cancer Research|January 28, 2012
Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transitionDingcheng Gao, Natasha Joshi, Hyejin Choi, et al.
Oncotarget|November 19, 2016
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancerMichael John Sax, Christin Gasch, Vineel Rag Athota, et al.
Nature Communications|December 16, 2021
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasisDivya Ramchandani, Mirela Berisa, Diamile A Tavarez, et al.
Nature|November 13, 2015
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistanceKari R Fischer, Anna Durrans, Sharrell Lee, et al.
Science Translational Medicine|September 1, 2017
Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosisZhongwei Cao, Tinghong Ye, Yue Sun, et al.
Pageof 11